Newstral
Novartis
- Industry Reacts to USPTO Guidance on Using AI to Innovatejdsupra.com
- Compliant Marketing In The Pharmaceutical Industry's Regulatory MazeForbes
- AlphaFold 3 unlocks a new scientific era, mastering 'all of life's molecules'newatlas.com
- Google DeepMind’s Groundbreaking AI for Protein Structure Can Now Model DNAWired.com
- Meet The Swiss Start-Up Bringing Medicines To Lower Income NationsForbes
- In re Cellect Poses an Obvious Dilemmajdsupra.com
- Biosimilar Launch and Approval Updates – Tyenne® (tocilizumab-aazg), Xlucane™ (ranibizumab), Hercessi™ (trastuzumab-strf)jdsupra.com
- TAnalyse: Novartis-Übernahmeziel MorphoSys plötzlich im Fokus der Leerverkäuferthemarket.ch
- IArvinas inks over $1.0 billion deal with Novartisinvezz.com
- Celltrion Submits aBLA for CT-P39, Proposed Interchangeable Biosimilar of Xolair® (omalizumab)jdsupra.com
- Business Tech Roundup: CEOs Are Using LinkedIn To Become Their Own Brand AmbassadorsForbes
- CUBS CEO Sergio Ermotti Open to Prolonged Tenure Amid Integration Challenges While His Wealth Seriously Adds Upceoworld.biz
- How The World’s Most Valuable Firms Are Upending The Concept Of ManagementForbes
- Asthma Drug Xolair Now Indicated For Food Allergies: Next Challenge Is Insurer CoverageForbes
- CSanofi CEO Paul Hudson’s salary takes another dip to €10.57 millionceoworld.biz
- Stanford-led study offers relief to children with dangerous food allergies, leading to FDA drug approvalSan Jose Mercury News
- TFDA Expands Use of Asthma Drug Xolair to Treat Severe Food Allergiestheepochtimes.com
- FDA expands use of asthma drug Xolair to treat severe food allergiesSeattle Times
- TLisa Jarvis: A cure for some kinds of hearing loss? Gene therapies are getting closertwincities.com
- KGoFundMe has become a health care utilitykffhealthnews.org
Frequent names
Newstral's extraction of names of people and organisations from the world's news is completely automated. If you do not want your name to appear here, please contact us. We will be happy to look at your request.